Stock Market Blog
Daily stock market analysis, trade alerts, and trading education from Ross Givens and the Traders Agency team.
You Don’t Have to Believe the SpaceX Hype
There is a powerful trading edge that 99% of traders will never be able to achieve. And the kicker is – it has nothing to do with market knowledge.
AI Agents Are Coming... These 3 Stocks Could Go PARABOLIC
Agentic AI stocks are entering a new phase as 1.4B knowledge workers replace chatbots with autonomous agents. These 3 backdoor infrastructure plays could e
Oracle Shares Tumble 11%: Cash Burn Concerns
Oracle shares tumble 11% after a $20B capital raise and negative $23.7B free cash flow alarm traders. Revenue beat, but the cash burn tells a darker story.
ECB Rate Decision June 2026: Hike Hits Traders
ECB rate decision June 2026 delivers a 25bps hike to 2.25% as Iran war drives inflation to 3%. Here's what it means for euro and energy trades.
Could the SpaceX IPO End the Pullback?
The pullback continues. But the question on people’s minds is – could the SpaceX IPO end the pullback? Ross investigates.
Crypto vs Traditional Markets: Key Differences
Crypto vs traditional markets explained: 24/7 trading, volatility, and regulation compared. Learn how crypto liquidity and structure differ from stocks.
SpaceX Share Flipping Risk: Cramer's IPO Warning
SpaceX share flipping risk is real — the IPO is 4x oversubscribed, but Jim Cramer warns short-term speculators could tank early price action.
Stock Market Today: S&P 500 Falls 1.6% on Iran
Stock market today: S&P 500 dropped 1.6% as Trump threatened Iran strikes, sending oil to $90.50 and VIX spiking to 21.80. Which sectors held green?
Setting Up Alerts on Thinkorswim
Learn how thinkorswim price alerts work — from basic triggers to ThinkScript conditions — so you can monitor trades without watching screens all day.
Precious Metals Decline: Gold, Silver & BTC Drop
Precious metals decline accelerates as Fed rate hike bets push real yields higher. Gold hits $4,161, silver ETFs bleed — here's what traders are watching n
The FDA Said NO Twice... Then Everything Changed for This $1 Stock
FDA drug rejection reversal almost never happens — but it did for Outlook Therapeutics. OTLK trades under $1 with an FDA decision due in roughly 60 days.
The Ultimate Trading Edge?
There is a powerful trading edge that 99% of traders will never be able to achieve. And the kicker is – it has nothing to do with market knowledge.
Stop watching.
Start winning.
50,000+ traders get our daily brief before the market opens.
You're subscribed!
Check your inbox.
Free. No spam. Unsubscribe anytime.
